What is known about the safety of Kiovig (human immunoglobulin) during pregnancy?

Kiovig’s safety during pregnancy has not been established in controlled clinical trials, so it should be given cautiously; intravenous immunoglobulins cross the placenta increasingly during the third trimester, although clinical experience suggests no harmful effects on pregnancy, the foetus or newborn are expected.